Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 8.77%1.33B | 0.53%2.37B | -1.36%1.23B | 6.54%2.36B | 13.58%1.24B | 8.09%2.22B | 0.82%1.09B | 3.06%2.05B | 7.30%1.08B | 4.50%1.99B |
| Operating income | 8.77%1.33B | 0.53%2.37B | -1.36%1.23B | 6.54%2.36B | 13.58%1.24B | 8.09%2.22B | 0.82%1.09B | 3.06%2.05B | 7.30%1.08B | 4.50%1.99B |
| Cost of sales | -9.22%-1.2B | -0.59%-2.13B | 1.40%-1.1B | -8.87%-2.11B | -15.86%-1.12B | -6.81%-1.94B | 0.27%-964.89M | -5.00%-1.82B | -6.65%-967.55M | -2.29%-1.73B |
| Operating expenses | -9.22%-1.2B | -0.59%-2.13B | 1.40%-1.1B | -8.87%-2.11B | -15.86%-1.12B | -6.81%-1.94B | 0.27%-964.89M | -5.00%-1.82B | -6.65%-967.55M | -2.29%-1.73B |
| Gross profit | 4.69%128.97M | 0.01%245.99M | -1.05%123.19M | -10.00%245.96M | -3.44%124.5M | 18.21%273.29M | 9.88%128.93M | -10.07%231.19M | 12.98%117.34M | 22.26%257.08M |
| Selling expenses | -16.08%-55.03M | -3.48%-104.74M | -8.79%-47.4M | -12.23%-101.22M | -13.24%-43.57M | -3.18%-90.19M | 4.22%-38.48M | -16.26%-87.41M | -1.87%-40.18M | 11.38%-75.18M |
| Administrative expenses | -4.86%-33.44M | 4.44%-63.14M | -5.78%-31.9M | -7.04%-66.08M | -0.67%-30.15M | 1.24%-61.73M | -15.80%-29.95M | -9.00%-62.51M | 9.52%-25.86M | 12.52%-57.35M |
| Revaluation surplus | ---- | -91.67%-2.3M | ---- | 47.83%-1.2M | ---- | ---2.3M | ---- | ---- | ---- | -183.33%-1.5M |
| -Changes in the fair value of investment property | ---- | -91.67%-2.3M | ---- | 47.83%-1.2M | ---- | ---2.3M | ---- | ---- | ---- | -183.33%-1.5M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | 29.90%-1.55M | ---3.96M | 63.45%-2.21M | ---- |
| Special items of operating profit | -42.72%7.11M | 17.83%88.91M | -80.77%12.41M | 14.50%75.45M | 1,834.65%64.53M | 488.00%65.89M | 96.69%-3.72M | -958.16%-16.98M | -93,740.00%-112.37M | -53.22%1.98M |
| Operating profit | -15.44%47.61M | 7.72%164.72M | -51.17%56.3M | -17.33%152.91M | 108.77%115.3M | 206.56%184.97M | 187.27%55.23M | -51.74%60.34M | -311.65%-63.29M | 89.72%125.03M |
| Financing income | 523.53%530K | 146.59%614K | -37.50%85K | 57.59%249K | --136K | --158K | ---- | ---- | ---- | 108.72%359K |
| Financing cost | -29.48%-729K | 54.66%-1.16M | 61.88%-563K | 27.70%-2.56M | ---1.48M | ---3.55M | ---- | ---- | ---- | 64.02%-8.52M |
| Share of profits of associates | 142.25%3.32M | 332.52%3.92M | 40.22%-7.87M | 97.29%-1.69M | 61.17%-13.16M | -104.41%-62.2M | -70.24%-33.9M | 52.07%-30.43M | -7.09%-19.91M | -666.02%-63.48M |
| Earning before tax | 5.78%50.73M | 12.88%168.09M | -52.42%47.96M | 24.73%148.91M | 372.52%100.8M | 299.16%119.39M | 125.64%21.33M | -43.98%29.91M | -835.66%-83.2M | 56.55%53.39M |
| Tax | 6.49%-9.22M | -6.65%-18.77M | -1.51%-9.86M | 1.16%-17.6M | 3.11%-9.71M | 30.94%-17.8M | -5.13%-10.02M | 8.11%-25.78M | 54.42%-9.53M | -89.57%-28.05M |
| After-tax profit from continuing operations | 8.96%41.52M | 13.71%149.32M | -58.17%38.1M | 29.27%131.32M | 705.40%91.09M | 2,358.49%101.59M | 112.20%11.31M | -83.69%4.13M | -865.03%-92.73M | 31.23%25.34M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 925.66%830.81M |
| Earning after tax | 8.96%41.52M | 13.71%149.32M | -58.17%38.1M | 29.27%131.32M | 705.40%91.09M | 2,358.49%101.59M | 112.20%11.31M | -99.52%4.13M | -112.18%-92.73M | 753.51%856.14M |
| Minority shareholders should account for non-continuing business profits | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -102.22%-156K |
| Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -102.22%-156K |
| Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 31.23%25.34M |
| Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,023.38%830.96M |
| Profit attributable to shareholders | 8.96%41.52M | 13.71%149.32M | -58.17%38.1M | 29.27%131.32M | 705.40%91.09M | 2,358.49%101.59M | 112.20%11.31M | -99.52%4.13M | -112.18%-92.73M | 818.03%856.3M |
| Basic earnings per share | 8.97%0.0498 | 13.71%0.1791 | -58.19%0.0457 | 29.20%0.1575 | 703.68%0.1093 | 2,338.00%0.1219 | 112.20%0.0136 | -99.52%0.005 | -112.12%-0.1115 | 794.98%1.0337 |
| Diluted earnings per share | 7.44%0.0491 | 13.65%0.179 | -58.19%0.0457 | 29.31%0.1575 | 709.63%0.1093 | 2,385.71%0.1218 | 112.11%0.0135 | -99.53%0.0049 | -112.12%-0.1115 | 842.34%1.0328 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.